—  SPECIALTY CONFERENCE  —

Gynecologic Pathology

Case 2 - Metastatic Poorly Differentiated Endometrioid Adenocarcinoma Arising in Adenomyosis

Lora Hedrick Ellenson
Weill Medical College of Cornell University
New York, NY





Virtual Slides as well as Still Images are displayed below.
For the fastest viewing of virtual slides, click:



under each thumbnail image below. You must have Aperio ImageScope installed on your PC.
If you do not already have Aperio ImageScope, Windows users with administrator privileges may download and install a free version in order to view USCAP Virtual Slides. Click the icon on the right to get your free copy:  
Or, click on slide thumbnail images to view each slide
in a Web-based slide viewer, which is somewhat slower.

If you have any difficulties viewing these slides, email or call George Clay at +1.724.449.1137.



Click here to download handout in 1-up pdf format for the current section (16.7 MB)

Click here to download handout in 6-up pdf format for the current section (1.47 MB)



Clinical History:
35-year-old G0 woman with a unilateral adnexal cystic mass.


Case 2 - Slide 1
Click to view with ImageScope
Click to view with a Web-Based Viewer



Case 2 - Figure 1

Case 2 - Figure 2

Case 2 - Figure 3

Case 2 - Figure 4

Case 2 - Figure 5
Mucicarmine

Case 2 - Figure 6
CK7

Case 2 - Figure 7
CK20

Case 2 - Figure 8
ER

Case 2 - Figure 9
PR

Case 2 - Figure 10
WT-1


Differential Diagnosis:
  • Metastatic gastric carcinoma

  • Poorly differentiated carcinoma of the ovary

  • Metastatic endometrial carcinoma

Final Diagnosis:
Metastatic poorly differentiated endometrioid adenocarcinoma arising in adenomyosis

References:
  1. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Walsh MD et al. Clin Cancer Res. 2008 March 15; 4(6):1692-700.

  2. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. Zighelboim I et al. J Clin Oncol. 2007 May 20; 25(15):2042-8.

  3. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Modica I et al. Am J Surg Pathol. 2007 May; 31(5):744-51.

  4. Body mass index: relationship to clinical, pathological and features of microsatellite instability in endometrial cancer. McCourt CK et al. Gynecol Oncol. 2007 Mar;104(3):535-9.